〇Takashi Tominaga^1,2, Pooja Gusain^1,3, Makiko Taketoshi^1,2, Yoko Tominaga^1,2 (1.Inst Neurosci, Tokushima Bunri Univ, 2.Kagawa Sch Pharm Sci, Tokushima Bunri Univ, 3.Dept Ophth, Sch Med, Keio Univ)

〇Yutaka Shindo¹, Zefeng Wei¹, Mitsuru Iizumi¹, Ryu Yamanaka², Kohji Hotta¹, Kotaro Oka^1,3,4 (1.Fac Sci Tech, Keio Univ, Kanagawa, Japan, 2.Fac Pharmac Sci, Sanyo-Onoda City Univ, Yamaguchi, Japan, 3.Grad Inst Med, Col Med, Kaohsiung Med Univ, Kaohsiung, Taiwan, 4.Waseda Res Inst Sci Eng, Waseda Univ, Tokyo, Japan)

〇Keisuke Ota^1,2, Yasuhiro Oisi², Muneki Ikeda ^3,4,2, Yoshiki Ito ^1,2, Hiroyuki Uwamori², Shun Kimura⁵, Kenta Kobayashi⁶, Yoshinori Kuroiwa ⁷, Masaru Horikoshi ⁷, Junya Matsushita ⁸, Hiroyuki Hioki ⁹, Masamichi Ohkura ¹⁰, Junichi Nakai ¹¹, Koujin Takeda ⁵, Masafumi Oizumi ^2,1, Atsushi Miyawaki ², Toru Aonishi ¹², Takahiro Ode ¹³, Bito Haruhiko ¹, Masanori Murayama ² (1.The University of Tokyo, Tokyo, Japan, 2.RIKEN Center for Brain Science, Saitama, Japan, 3.University of California San Francisco, San Francisco, USA, 4.Indiana University Bloomington, Bloomington, USA, 5.Ibaraki University, Hitachi, Japan, 6.National Institute for Physiological Sciences, Okazaki, Japan, 7.Nikon Corporation, Yokohama, Japan, 8.Hamamatsu Photonics K.K., Iwata-shi, Japan, 9.Juntendo University, Tokyo, Japan, 10.Kyushu University of Health and Welfare, Miyazaki, Japan, 11.Tohoku University, Miyagi, Japan, 12.Tokyo Institute of Technology, Yokohama, Japan, 13.FOV Corporation, Yokohama, Japan)